{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:50:29Z","timestamp":1770504629533,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012462","name":"Office of Academic Affiliations, Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NO1 MH90001"],"award-info":[{"award-number":["NO1 MH90001"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.schres.2011.07.032","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T05:16:17Z","timestamp":1314594977000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Substance use and schizophrenia: Adverse correlates in the CATIE study sample"],"prefix":"10.1016","volume":"132","author":[{"given":"Karin E.","family":"Kerfoot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismene L.","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin S.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.E.","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Scott","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2011.07.032_bb0010","first-page":"99","article-title":"Substance abuse and cognitive functioning in schizophrenia","volume":"22","author":"Addington","year":"1997","journal-title":"J. Psychiatry Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2011.07.032_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2011.07.032_bb0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02249430","article-title":"Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach","volume":"32","author":"Carey","year":"1996","journal-title":"Community Ment. Health J."},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"122","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"issue":"Suppl.","key":"10.1016\/j.schres.2011.07.032_bb0025","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0920-9964(98)00161-3","article-title":"Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes","volume":"35","author":"Dixon","year":"1999","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2011.07.032_bb0045","first-page":"1041","article-title":"Substance abuse among the chronic mentally ill","volume":"40","author":"Drake","year":"1989","journal-title":"Hosp. Community Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2011.07.032_bb0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00005053-198907000-00004","article-title":"Alcohol use and abuse in schizophrenia. A prospective community study","volume":"177","author":"Drake","year":"1989","journal-title":"J. Nerv. Ment. Dis."},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/schbul\/16.1.57","article-title":"Diagnosis of alcohol use disorders in schizophrenia","volume":"16","author":"Drake","year":"1990","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2011.07.032_bb0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1176\/ajp.150.2.328","article-title":"Treatment of alcoholism among schizophrenic outpatients: 4-year outcomes","volume":"150","author":"Drake","year":"1993","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0920-9964(98)00177-7","article-title":"Alcohol dependence and hospitalization in schizophrenia","volume":"38","author":"Gerding","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.07.032_bb0055","series-title":"ECDEU Assessment Manual for Psychopharmacology\u2014Revised","author":"Guy","year":"1976"},{"issue":"7","key":"10.1016\/j.schres.2011.07.032_bb0060","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1176\/ps.49.7.935","article-title":"Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients","volume":"49","author":"Havassy","year":"1998","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.schres.2011.07.032_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: an instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00952999309002667","article-title":"Three-month follow-up of 28 dual diagnosis inpatients","volume":"19","author":"Hoffman","year":"1993","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.schres.2011.07.032_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0920-9964(02)00387-0","article-title":"Drug abuse and\/or dependence and better neuropsychological performance in patients with schizophrenia","volume":"63","author":"Joyal","year":"2003","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2011.07.032_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.schbul.a006990","article-title":"Neurocognitive assessment in the clinical antipsychotic trials of intervention effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale","volume":"29","author":"Keefe","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2011.07.032_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2011.07.032_bb0095","series-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","article-title":"The EuroQol instrument: an index of health-related quality of life","author":"Kind","year":"1996"},{"key":"10.1016\/j.schres.2011.07.032_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0149-7189(88)90033-X","article-title":"A quality of life interview for the chronically mentally ill","volume":"11","author":"Lehman","year":"1988","journal-title":"Eval. Program Plann."},{"issue":"12","key":"10.1016\/j.schres.2011.07.032_bb0105","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.schres.2011.07.032_bb0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0306-4603(96)00042-1","article-title":"Harm reduction: come as you are","volume":"21","author":"Marlatt","year":"1996","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-1781(96)02911-3","article-title":"Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients","volume":"64","author":"Nixon","year":"1996","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.schres.2011.07.032_bb0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1176\/ps.47.8.853","article-title":"Medication noncompliance and substance abuse among patients with schizophrenia","volume":"47","author":"Owen","year":"1996","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1139\/jpn.0305","article-title":"Substance use and cognition in early psychosis","volume":"28","author":"Pencer","year":"2003","journal-title":"J. Psychiatry Neurosci."},{"issue":"19","key":"10.1016\/j.schres.2011.07.032_bb0130","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2011.07.032_bb0135","series-title":"Antipsychotic Trials in Schizophrenia","first-page":"189","article-title":"Substance use in persons with schizophrenia: incidence, baseline correlates, and effects on outcome","author":"Reimherr","year":"2010"},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-9964(00)00063-3","article-title":"Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia","volume":"48","author":"Salyers","year":"2001","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2011.07.032_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2011.07.032_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/ajp.155.2.226","article-title":"Violence and severe mental illness: the effects of substance abuse and nonadherence to medication","volume":"155","author":"Swartz","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2011.07.032_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.nmd.0000202575.79453.6e","article-title":"Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study","volume":"194","author":"Swartz","year":"2006","journal-title":"J. Nerv. Ment. Dis."},{"issue":"8","key":"10.1016\/j.schres.2011.07.032_bb0160","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/ps.2006.57.8.1110","article-title":"Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study","volume":"57","author":"Swartz","year":"2006","journal-title":"Psychiatr. Serv."},{"issue":"1\u20133","key":"10.1016\/j.schres.2011.07.032_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.schres.2007.11.034","article-title":"The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study","volume":"100","author":"Swartz","year":"2008","journal-title":"Schizophr. Res."},{"issue":"1\u20132","key":"10.1016\/j.schres.2011.07.032_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-9964(95)00068-2","article-title":"Substance use: a powerful predictor of relapse in schizophrenia","volume":"20","author":"Swofford","year":"1996","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2011.07.032_bb0175","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/appi.ajp.161.4.716","article-title":"Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders","volume":"161","author":"Wallace","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2011.07.032_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10550490600860114","article-title":"Comorbid schizophrenia and substance abuse: a review of epidemiology and course","volume":"15","author":"Westermeyer","year":"2006","journal-title":"Am. J. Addict."},{"issue":"4","key":"10.1016\/j.schres.2011.07.032_bb0185","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.149.4.552","article-title":"Past substance abuse and clinical course of schizophrenia","volume":"149","author":"Zisook","year":"1992","journal-title":"Am. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411004300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411004300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:23:34Z","timestamp":1760297014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411004300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":37,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0920996411004300"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.07.032","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance use and schizophrenia: Adverse correlates in the CATIE study sample","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2011.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}